Tci Wealth Advisors, Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$14.26 - $22.1 $4,135 - $6,409	290 New	290 $4,000
Q4 2021 Jan 24, 2022	SELL	$7.7 - $37.13 $693 - $3,341	-90 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$26.46 - $37.15 $2,381 - $3,343	90 New	90 $3,000
Q2 2021 Aug 02, 2021	SELL	$32.73 - $47.95 $1,505 - $2,205	-46 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$40.39 - $56.73 $1,857 - $2,609	46 New	46 $2,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.